These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 20346231

  • 21. The first year results of mizoribine/tacrolimus-based multitarget treatment for consecutive patients with lupus nephritis.
    Kagawa H, Hiromasa T, Yamanaka R, Hayashi R, Tsunashima Y, Inoue T, Sada KE.
    Clin Exp Nephrol; 2018 Dec; 22(6):1371-1378. PubMed ID: 29948442
    [Abstract] [Full Text] [Related]

  • 22. Clinical efficacy of cyclosporin a neoral in the treatment of paediatric lupus nephritis with heavy proteinuria.
    Fu LW, Yang LY, Chen WP, Lin CY.
    Br J Rheumatol; 1998 Feb; 37(2):217-21. PubMed ID: 9569080
    [Abstract] [Full Text] [Related]

  • 23. Efficacy and safety of multi-target therapy using a combination of tacrolimus, mycophenolate mofetil and a steroid in patients with active lupus nephritis.
    Ikeuchi H, Hiromura K, Takahashi S, Mishima K, Sakurai N, Sakairi T, Kaneko Y, Maeshima A, Kuroiwa T, Nojima Y.
    Mod Rheumatol; 2014 Jul; 24(4):618-25. PubMed ID: 24252014
    [Abstract] [Full Text] [Related]

  • 24. Treatment of membranous lupus nephritis with nephrotic syndrome by sequential immunosuppression.
    Chan TM, Li FK, Hao WK, Chan KW, Lui SL, Tang S, Lai KN.
    Lupus; 1999 Jul; 8(7):545-51. PubMed ID: 10483033
    [Abstract] [Full Text] [Related]

  • 25. Identification of biomarkers that predict response to treatment of lupus nephritis with mycophenolate mofetil or pulse cyclophosphamide.
    Dall'Era M, Stone D, Levesque V, Cisternas M, Wofsy D.
    Arthritis Care Res (Hoboken); 2011 Mar; 63(3):351-7. PubMed ID: 21080348
    [Abstract] [Full Text] [Related]

  • 26. Mizoribine treatment of young patients with severe lupus nephritis: a clinicopathologic study by the tohoku pediatric study group.
    Tanaka H, Oki E, Tsuruga K, Sato N, Matsukura H, Matsunaga A, Kondo Y, Suzuki J.
    Nephron Clin Pract; 2008 Mar; 110(2):c73-9. PubMed ID: 18758186
    [Abstract] [Full Text] [Related]

  • 27. Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis.
    Li X, Ren H, Zhang Q, Zhang W, Wu X, Xu Y, Shen P, Chen N.
    Nephrol Dial Transplant; 2012 Apr; 27(4):1467-72. PubMed ID: 21917733
    [Abstract] [Full Text] [Related]

  • 28. [Evaluation of serum C3 and CH50 levels as markers of disease-activity and indicators of efficacy of treatment of lupus nephritis in childhood].
    Ibe M, Kuriyama T, Mori M, Mitsuda T, Aihara Y, Yokota S.
    Ryumachi; 1994 Aug; 34(4):715-24. PubMed ID: 7974022
    [Abstract] [Full Text] [Related]

  • 29. Combination therapy of mycophenolate mofetil and tacrolimus in lupus nephritis.
    Lanata CM, Mahmood T, Fine DM, Petri M.
    Lupus; 2010 Jul; 19(8):935-40. PubMed ID: 20388722
    [Abstract] [Full Text] [Related]

  • 30. Pilot 24 month study to compare mycophenolate mofetil and tacrolimus in the treatment of membranous lupus nephritis with nephrotic syndrome.
    Yap DY, Yu X, Chen XM, Lu F, Chen N, Li XW, Tang CS, Chan TM.
    Nephrology (Carlton); 2012 May; 17(4):352-7. PubMed ID: 22295934
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Combined therapy of low-dose tacrolimus and prednisone in nephrotic syndrome with slight mesangial proliferation.
    Miao L, Sun J, Yuan H, Jia Y, Xu Z.
    Nephrology (Carlton); 2006 Oct; 11(5):449-54. PubMed ID: 17014560
    [Abstract] [Full Text] [Related]

  • 33. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
    Moroni G, Doria A, Mosca M, Alberighi OD, Ferraccioli G, Todesco S, Manno C, Altieri P, Ferrara R, Greco S, Ponticelli C.
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Mizoribine therapy for patients with lupus nephritis: the association between peak mizoribine concentration and clinical efficacy.
    Kuroda T, Hirose S, Tanabe N, Sato H, Nakatsue T, Ajiro J, Wada Y, Murakami S, Hasegawa H, Ito S, Sakatsume M, Nakano M, Gejyo F.
    Mod Rheumatol; 2007 Sep; 17(3):206-12. PubMed ID: 17564775
    [Abstract] [Full Text] [Related]

  • 36. Mizoribine, tacrolimus, and corticosteroid combination therapy successfully induces remission in patients with lupus nephritis.
    Kagawa H, Hiromasa T, Hara T, Takaki A, Yamanaka R, Sada KE, Makino H.
    Clin Exp Nephrol; 2012 Oct; 16(5):760-6. PubMed ID: 22492013
    [Abstract] [Full Text] [Related]

  • 37. Good response of membranous lupus nephritis to tacrolimus.
    Maruyama M, Yamasaki Y, Sada K, Sarai A, Ujike K, Maeshima Y, Nakamura Y, Sugiyama H, Makino H.
    Clin Nephrol; 2006 Apr; 65(4):276-9. PubMed ID: 16629227
    [Abstract] [Full Text] [Related]

  • 38. Mycophenolate mofetil treatment in children and adolescents with lupus.
    Kazyra I, Pilkington C, Marks SD, Tullus K.
    Arch Dis Child; 2010 Dec; 95(12):1059-61. PubMed ID: 20810399
    [Abstract] [Full Text] [Related]

  • 39. Implication of the peak serum level of mizoribine for control of the serum anti-dsDNA antibody titer in patients with lupus nephritis.
    Tanaka H, Tsugawa K, Nakahata T, Kudo M, Suzuki K, Ito E.
    Clin Nephrol; 2005 Jun; 63(6):417-22. PubMed ID: 15960142
    [Abstract] [Full Text] [Related]

  • 40. Outcomes of maintenance therapy with tacrolimus versus azathioprine for active lupus nephritis: a multicenter randomized clinical trial.
    Chen W, Liu Q, Chen W, Tang X, Fu P, Liu F, Liao Y, Yang Z, Zhang J, Chen J, Lou T, Fu J, Kong Y, Liu Z, Li Z, Yu X.
    Lupus; 2012 Aug; 21(9):944-52. PubMed ID: 22438027
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.